Impact of Sociodemographic Factors on Efficacy and Safety of Tofacitinib in Patients with Rheumatoid Arthritis: A Post Hoc Analysis of Phase 2/3/3b/4 Studies

被引：0
|
作者：
Wright, Grace [1 ]
Mysler, Eduardo [2 ]
Roberts, Kevin [3 ]
Sweet, Lindsay [4 ]
Shelbaya, Ahmed [5 ]
机构：
[1] Grace C Wright MD PC, New York, NY USA
[2] Organizac Med Invest, Buenos Aires, DF, Argentina
[3] Pfizer Inc, Cambridge, MA USA
[4] Pfizer Inc, Collegeville, PA USA
[5] Pfizer Inc, New York, NY USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2113
引用
收藏
页码：4172 / 4175
页数：4
相关论文
共 50 条
  • [21] Impact of Tofacitinib on the Individual Components of the ACR Composite Score in Patients with Rheumatoid Arthritis: A Post Hoc Analysis of Phase 3 Trials
    Bessette, Louis
    Dougados, Maxime
    Mysler, Eduardo
    Genovese, Mark
    Kinch, Cassandra
    Kwok, Kenneth
    Lukic, Tatjana
    Girard, Tanya
    Landry, Pierre-Alexandre
    van Vollenhoven, Ronald
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [22] Impact of Tofacitinib on the Individual Components of the ACR Composite Score in Patients With Rheumatoid Arthritis: A Post Hoc Analysis of Phase 3 Trials
    Bessette, Louis
    Dougados, Maxime
    Mysler, Eduardo
    Genovese, Mark
    Kinch, Cassandra
    Kwok, Kenneth
    Lukic, Tatjana
    Girard, Tanya
    Landry, Pierre-Alexandre
    van Vollenhoven, Ronald
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1106 - 1107
  • [23] AGE-BASED (<65 VS ≥65 YEARS) INCIDENCE OF INFECTIONS AND SERIOUS INFECTIONS IN TOFACITINIB-, ADALIMUMAB- AND PLACEBO-TREATED PATIENTS WITH RHEUMATOID ARTHRITIS: A POST HOC ANALYSIS OF PHASE 2, PHASE 3 AND PHASE 3B/4 TOFACITINIB STUDIES
    Winthrop, K.
    Gold, D.
    Henrohn, D.
    Wang, L.
    Shapiro, A.
    Shi, H.
    Citera, G.
    Schulze-Koops, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1003 - 1004
  • [24] EFFICACY OF ADALIMUMAB AND TOFACITINIB IN RHEUMATOID ARTHRITIS: POST-HOC ANALYSES FROM A PHASE 3 STUDY
    van Vollenhoven, R.
    Cohen, S.
    Mendelsohn, A.
    Bananis, E.
    Fan, H.
    Takiya, L.
    Fleischmann, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1042 - 1042
  • [25] TOFACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS AND METABOLIC SYNDROME: A POST-HOC ANALYSIS OF PHASE 3 STUDIES
    Ritchlin, C.
    Giles, J.
    Ogdie, A.
    Gomez-Reino, J.
    Stockert, L.
    Young, P.
    Wang, C.
    Romero, A. B.
    Kudlacz, E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1023 - 1023
  • [26] Efficacy and Safety of Tofacitinib in Patients with Ankylosing Spondylitis by Baseline BMI: A Post Hoc Analysis of Phase 2 and Phase 3 Trials
    Norton, Hillary
    Sliwinska-Stanczyk, Paula
    Hala, Tomas
    Elzorkany, Bassel
    Stockert, Lori
    Shi, Harry
    Wang, Cunshan
    Paulissen, Jerome
    Ritchlin, Christopher
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 800 - 803
  • [27] Efficacy and safety of tofacitinib in patients with active rheumatoid arthritis: review of key Phase 2 studies
    Fleischmann, Roy
    Kremer, Joel
    Tanaka, Yoshiya
    Gruben, David
    Kanik, Keith
    Koncz, Tamas
    Krishnaswami, Sriram
    Wallenstein, Gene
    Wilkinson, Bethanie
    Zwillich, Samuel H.
    Keystone, Edward
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2016, 19 (12) : 1216 - 1225
  • [28] Efficacy and Safety of Upadacitinib in Patients Across Races with Rheumatoid Arthritis: A Post Hoc Analysis of Six Phase 3 Clinical Trials
    Wright, Grace
    Mysler, Eduardo
    Navarro-Millan, Iris
    Tanaka, Yoshiya
    Anyanwu, Samuel
    Liu, Jianzhong
    Tanjinatus, Oishi
    Garrison, Andrew
    Wells, Alvin
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 548 - 550
  • [29] EFFICACY OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS WITH POOR PROGNOSTIC FACTORS: POST HOC ANALYSIS OF FINCH 3
    Aletaha, D.
    Westhovens, R.
    Gaujoux-Viala, C.
    Adami, G.
    Matsumoto, A.
    Bird, P.
    Messina, O.
    Buch, M. H.
    Bartok, B.
    Yin, Z.
    Guo, Y.
    Hendrikx, T.
    Burmester, G. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 308 - 309
  • [30] Efficacy of Filgotinib in Patients with Rheumatoid Arthritis with Poor Prognostic Factors: Post Hoc Analysis of FINCH 3
    Westhovens, Rene
    Aletaha, Daniel
    Gaujoux-Viala, Cecile
    Adami, Giovanni
    Matsumoto, Alan
    Bird, Paul
    Messina, Osvaldo
    Buch, Maya
    Bartok, Beatrix
    Yin, Zhaoyu
    Guo, Ying
    Hendrikx, Thijs
    Burmester, Gerd
    SWISS MEDICAL WEEKLY, 2020, : 9S - 10S
12345